22 August 2024 | News
Industry leaders convene in Pune for a pivotal two-day event focused on advancing vaccine innovation and accessibility, inaugurated by Bharat Biotech's Dr. Krishna Ella.
The 3rd Edition of the India Vaccine Leaders’ Conclave (IVLC) officially kicked off today at the prestigious Pune Vivanta By Taj, marking another milestone in the country’s ongoing efforts to advance vaccine development and deployment. The event, organized by Blue Tech Media, is being held on August 22nd and 23rd, 2024, bringing together leading minds and industry stakeholders in the vaccine ecosystem.
The Conclave was inaugurated by Chief Guest Dr. Krishna Ella, Founder and Executive Chairman of Bharat Biotech International. Dr. Ella, a pioneering figure in the vaccine industry, delivered the keynote address, emphasizing the critical role of innovation, collaboration, and resilience in the face of global health challenges. His insights set the tone for a series of thought-provoking discussions and presentations that will unfold over the course of the two-day event.
The agenda for IVLC 2024 includes sessions on cutting-edge vaccine research, public health policy, and strategies for improving vaccine accessibility in India and beyond. Industry leaders, researchers, policymakers, and healthcare professionals are set to engage in dynamic conversations aimed at shaping the future of vaccines in the region.